A pharmaceutical company is currently appealing a record USD1.6 billion judgment in the US, arguing that a key part of the US False Claims Act (FCA) is unconstitutional. This case, now before the Court of Appeals for the...more
7/30/2025
/ Appeals ,
Constitutional Challenges ,
Enforcement Actions ,
False Claims Act (FCA) ,
Government Agencies ,
Healthcare Fraud ,
Medicare ,
Pharmaceutical Industry ,
SCOTUS ,
United States ex rel Polansky v Executive Health Resources Inc ,
Whistleblower Protection Policies ,
Whistleblowers